Original paper

Nicotinamide and Pyruvate for Neuroenhancement in Open-Angle Glaucoma

Volume: 140, Issue: 1, Pages: 11 - 11
Published: Jan 1, 2022
Abstract
Open-angle glaucoma may continue to progress despite significant lowering of intraocular pressure (IOP). Preclinical research has suggested that enhancing mitochondrial function and energy production may enhance retinal ganglion cell survival in animal models of glaucoma, but there is scant information on its effectiveness in a clinical setting.To test the hypothesis that a combination of nicotinamide and pyruvate can improve retinal ganglion...
Paper Details
Title
Nicotinamide and Pyruvate for Neuroenhancement in Open-Angle Glaucoma
Published Date
Jan 1, 2022
Volume
140
Issue
1
Pages
11 - 11
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.